IDWeek 2019: ViiV Healthcare to present 20 abstracts from its innovative R&D portfolio with focus on 2-drug and long-acting regimens and mental health impact of HIV

Presentations include six-year data for the investigational regimen of cabotegravir and rilpivirine.